SKU: BBG70≥ 99% HPLC
Glow BPC-157 10mg+GHK-CU 50mg+TB500 10mg
Research Compound · Research use only

Glow BPC-157 10mg+GHK-CU 50mg+TB500 10mgGlow is a lyophilized formulation containing BPC-157 (10mg), GHK-Cu (50mg), and TB-500 (10mg) for laboratory research.

$107.99/ vial · 70mg
In stock
Est. Arrival: 11/25/2026Ships today if ordered by 4PM EST
Select Size
Volume Discounts
1
Purity
99%+
Form
Lyophilized Powder
Quantity
70 mg
Storage
Store lyophilized at -20 °C, sealed, away from light and moisture
Batch / Lot
202612-01-GLOW
99%+ PurityHPLC · third-party
COA Includedlot 202611-01-GLOW
USA BasedMidwest Region
For Research Use Only. This product is intended for laboratory and scientific research purposes only. It is not a drug or dietary supplement and is not for human or veterinary consumption. Not intended to diagnose, treat, cure, or prevent any disease.
$107.99Glow BPC-157 10mg+GHK-CU 50mg+TB500 10mg · 70mg × 1

Product Details

Store at -20°C.


Disclaimer: For laboratory and research purposes only. Not intended for human consumption.

Frequently Asked Questions About Glow BPC-157 10mg+GHK-CU 50mg+TB500 10mg

Answers summarize published research and are provided for laboratory research purposes only.

Each component of the Glow blend has a distinct mechanism described in research. Researchers have reported that BPC-157 interacts with nitric oxide signaling and growth factor pathways in animal models. Published research suggests that GHK-Cu binds copper and modulates gene expression tied to extracellular matrix turnover. In vitro studies have shown that TB-500, the Thymosin Beta-4 peptide, sequesters actin monomers and affects cytoskeletal dynamics. The blend puts all three activities in one vial.
Most evidence for the Glow blend components comes from preclinical work. BPC-157 has been studied mainly in rodent models and remains investigational. GHK-Cu has a long record of in vitro and cell culture research plus topical cosmetic studies. Thymosin Beta-4, sold as TB-500, has been examined in animal models and in early clinical trials of the native protein. No published study has tested the three-peptide Glow combination as a single product.
The Glow BPC-157 10mg+GHK-CU 50mg+TB500 10mg blend is listed with a combined molecular weight of about 6723.9 g/mol and a combined molecular formula of C288H472CuN78O104S, reflecting the three peptides together. Biotech Compounds supplies the Glow blend at a purity of 99 percent or higher, and each lot is third-party tested, with the Certificate of Analysis available on the product page for review before purchase.

Purity, documented